&Partners’s Exponent EXPO Stock Holding History

&Partners’s Portfolio EXPO Stock Details EXPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.15M	Sell	17,541 -261	-1%	-$18.5K	0.01%	1217
2025 Q4	$1.24M	Sell	17,802 -58	-0.3%	-$4.07K	0.01%	1113
2025 Q3	$1.24M	Buy	17,860 +980	+6%	+$70K	0.01%	985
2025 Q2	$1.26M	Buy	16,880 +2,533	+18%	+$196K	0.01%	870
2025 Q1	$1.18M	Buy	14,347 +1,754	+14%	+$153K	0.01%	758
2024 Q4	$1.12M	Buy	12,593 +2,303	+22%	+$232K	0.01%	724
2024 Q3	$1.19M	Buy	10,290 +5,024	+95%	+$526K	0.02%	504
2024 Q2	$501K	Buy	+5,266	New	+$475K	0.02%	540

Other funds holding EXPO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

&Partners's EXPO Position: Q1 2026 in Review

&Partners reduced its Exponent (EXPO) stake by 1.5% in Q1 2026, selling an estimated $18.5K and leaving 17,541 shares worth $1.15M. The position accounts for 0.01% of the portfolio, ranked #1217.

&Partners first reported a position in EXPO in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.26M in Q2 2025. 360 funds tracked by Wall St. Rank hold EXPO as of Q1 2026.

&Partners held 17,541 shares of Exponent worth $1.15M as of Q1 2026.
&Partners sold 261 Exponent shares in Q1 2026, an estimated $18.5K.
Exponent made up 0.01% of &Partners's portfolio in Q1 2026, its #1217 holding.
&Partners first reported a position in Exponent in Q2 2024 and has held it in 8 quarters since.
&Partners's Exponent position peaked at $1.26M in Q2 2025.
360 funds tracked by Wall St. Rank held Exponent as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.